BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dev California Life Sciences
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220811T090000
DTEND;TZID=America/New_York:20220811T130000
DTSTAMP:20260405T134605
CREATED:20220414T195142Z
LAST-MODIFIED:20220420T164018Z
UID:7834-1660208400-1660222800@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 4  Actualizing Change
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities-pt-4-actualizing-change/
LOCATION:Live\, Online
CATEGORIES:Member Events,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220613
DTEND;VALUE=DATE:20220617
DTSTAMP:20260405T134605
CREATED:20220225T190703Z
LAST-MODIFIED:20220331T210625Z
UID:6711-1655078400-1655423999@dev.califesciences.org
SUMMARY:BIO International Convention 2022
DESCRIPTION:Location: San Diego\, CA \n  \nBIO is thrilled to be back in person for the 2022 International Convention happening in San Diego\, CA June 13-16. The Convention theme ‘LIMITLESS’ is our commitment to unlocking possibilities for our members and attendees while paving the path to the future of our industry. \nThe BIO International Convention attracts 15\,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application\, including drug discovery\, biomanufacturing\, genomics\, biofuels\, nanotechnology\, and cell therapy. \nVisit the California Life Sciences pavilion in booth #3727 \nRegister»
URL:https://dev.califesciences.org/event/bio-international-convention-2022/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://dev.califesciences.org/wp-content/uploads/2022/02/BIO2022-AffiliateToolkit-Social-908x512-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220524T110000
DTEND;TZID=America/New_York:20220524T160000
DTSTAMP:20260405T134605
CREATED:20220411T183212Z
LAST-MODIFIED:20220411T204606Z
UID:7411-1653390000-1653408000@dev.califesciences.org
SUMMARY:Fierce Pharma: Leaders in Life Sciences Forum
DESCRIPTION:Location: Virtual \n  \nThe Fierce Leaders in Life Sciences Forum brings together forward-thinking minds from today’s life sciences industry and features insights from C-suite and executive leadership on the end-to-end drug development process\, highlighting innovative approaches in today’s evolving healthcare landscape to conducting: \n\nR&D and translational science\nClinical development\nProduct commercialization\n\nTop Reasons to Attend\n\nIndustry Updates: Hear from biotech and big pharma executives on emerging trends and market dynamics\nGain Tactics for Better Collaboration: Hear best practices on connecting R&D and clinical teams to the commercials teams to develop an appropriate timeline and practice approach to bring a new product to launch\nLearn How to Plan: Understand how to develop a cohesive brand launch strategy with marketing communication that is effective and tailored to the needs of the regional associates\nStay Ahead of Current Trends: Learn how best to utilize competitive intelligence and market research throughout the launch process to validate ideas and identify potential for greater success\nNetworking Opportunities: Connect with senior leadership in the life sciences industry to gain insights and share best practices on daily challenges faced\n\n  \n \n  \nRegister» \n  \n 
URL:https://dev.califesciences.org/event/fierce-pharma-leaders-in-life-sciences-forum/
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220519T090000
DTEND;TZID=America/Los_Angeles:20220519T100000
DTSTAMP:20260405T134605
CREATED:20220419T200521Z
LAST-MODIFIED:20220420T155511Z
UID:8080-1652950800-1652954400@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization - Innovative Customer Engagement Models
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nInnovative Customer Engagement Models \nWhile the value of face-to-face\, personal HCP interactions remain impactful\, the efficacy\, adoption\, and ROI of digital\, non-personal engagement continues to increase. IQVIA experts will discuss the imperatives for an agile and flexible engagement model for emerging biopharma; one that’s fit for today’s realities while being ready for what tomorrow will bring. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-innovative-customer-engagement-models/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220519
DTEND;VALUE=DATE:20220521
DTSTAMP:20260405T134605
CREATED:20220224T233602Z
LAST-MODIFIED:20220331T210524Z
UID:6640-1652918400-1653091199@dev.califesciences.org
SUMMARY:Personalized Medicine Coalition: 16th Annual Personalized Medicine Conference
DESCRIPTION:Location: Dana Point\, CA \n  \nConvening more than 500 of the world’s leading clinicians\, industry executives\, investors\, patient advocates\, payers\, policy experts\, and researchers\, the 16th Annual Personalized Medicine Conference will facilitate a cross-sector exchange of perspectives on the scientific\, business\, and policy issues influencing the status and outlook for personalized medicine in the wake of a devastating pandemic that has upended the health care landscape. Participants will help chart a course toward a brighter future for patients and health systems. \nTo stay up-to-date about the conference and related issues in personalized medicine\, click here to join the Personalized Medicine Coalition’s mailing list. \n  \nRegister» \n 
URL:https://dev.califesciences.org/event/personalized-medicine-coalition-16th-annual-personalized-medicine-conference/
LOCATION:Ritz-Carlton Laguna Niguel\, Dana Point\, CA\, Dana Point\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220518T090000
DTEND;TZID=America/Los_Angeles:20220518T120000
DTSTAMP:20260405T134605
CREATED:20220419T200018Z
LAST-MODIFIED:20220420T163902Z
UID:8078-1652864400-1652875200@dev.califesciences.org
SUMMARY:IQVIA – Critical Success Factors For Commercialization Series – Asset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nAsset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy \nIQVIA experts will share perspectives on how emerging biopharma companies can demonstrate and communicate the value of new therapies by engaging thought leaders to ensure their innovation reaches the patients who need it. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-asset-success-starts-early-demonstrating-and-communicating-the-value-of-your-therapy/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220512T090000
DTEND;TZID=America/Los_Angeles:20220512T100000
DTSTAMP:20260405T134605
CREATED:20220419T195644Z
LAST-MODIFIED:20220420T154527Z
UID:8076-1652346000-1652349600@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Preparing to Enter the Market: A Focus on Market Access
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nPreparing to Enter the Market: A Focus on Market Access \nAsset success relies on strong engagement with the key stakeholders who will influence the path to the patient. Learn from IQVIA experts as they share key considerations for emerging biopharma companies who need to establish market access in the U.S. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-preparing-to-enter-the-market-a-focus-on-market-access/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220511T090000
DTEND;TZID=America/New_York:20220511T130000
DTSTAMP:20260405T134605
CREATED:20220325T193143Z
LAST-MODIFIED:20220420T155633Z
UID:7032-1652259600-1652274000@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 2 "Othering" People
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities/
LOCATION:Virtual
CATEGORIES:Industry Collaboration & Networking,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220511T090000
DTEND;TZID=America/Los_Angeles:20220511T100000
DTSTAMP:20260405T134605
CREATED:20220419T193126Z
LAST-MODIFIED:20220420T155241Z
UID:8070-1652259600-1652263200@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Emerging Biopharma Prevailing Trends
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nEmerging Biopharma Prevailing Trends \nHear key insights from the recently published IQVIA Institute report on the contribution of emerging biopharma to development and commercialization\, as well as prevailing commercial launch trends and the implications for a successful asset strategy. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220505T170000
DTEND;TZID=America/New_York:20220505T190000
DTSTAMP:20260405T134605
CREATED:20220413T191217Z
LAST-MODIFIED:20220413T191246Z
UID:7540-1651770000-1651777200@dev.califesciences.org
SUMMARY:OUTbio Bay Area Kick Off & Networking Event
DESCRIPTION:Location: South San Francisco \n\n \n\nOUTbio Bay Area is the Bay Area’s first biotech industry’s LGBTQ+ professionals group. Our mission is to empower the LGBTQ+ community and its allies in biotechnology and affiliated industries. We are a new Bay Area chapter of the original non-profit OUTbio organization that was started in Boston in 2015 and has over 1\,200 members. Join us in supporting the LGBTQ+ professional community as we launch this exciting new chapter! \n\nRegister» \n\nAttend the kick-off event on May 5th to learn more about OUTbio Bay Area\, network with other LGBTQ+ professionals and allies in the biotech industry and find out how you can become involved with the group. \nHors d’oeuvres and refreshments will be served. Proof of COVID vaccination and booster required. Please have your vaccination card (or photo) with you at the event. \nRSVP by registering for the event. \nWe look forward to seeing you there! \n\n\nBy registering for this event\, you are automatically signing up for OUTbio Bay Area emails. Email outbiobayarea@gmail.com if you would like to be removed from the email listing. \nThank you to our sponsors! \n\n \n\n  \n  \n  \n 
URL:https://dev.califesciences.org/event/outbio-bay-area-kick-off-and-networking-event/
LOCATION:California Life Sciences\, The Lighthouse Cafe\, 685 Gateway Boulevard\, South San Francisco\, CA\, 94080
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220504T100000
DTEND;TZID=America/Los_Angeles:20220504T110000
DTSTAMP:20260405T134605
CREATED:20220420T180350Z
LAST-MODIFIED:20220420T180450Z
UID:8097-1651658400-1651662000@dev.califesciences.org
SUMMARY:Copyright at Work
DESCRIPTION:If you’ve ever been puzzled by copyright questions\, don’t miss this opportunity to learn from the copyright experts and to expand your respect for intellectual property. Not only will you get answers to your copyright questions\, but you’ll also learn how to minimize your company’s exposure to illegal content use. Please join us for this engaging and educational webcast. \nThis session features: \n\nThe basics of copyright law\nWhat is and what is not copyright protected\nFair use – what it is and how it works\nWhen copyright permission is needed\, for both photocopies and electronic content\nHow to obtain copyright permission and much more…\n\nRegister»
URL:https://dev.califesciences.org/event/copyright-at-work/
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220426T080000
DTEND;TZID=America/Los_Angeles:20220428T110000
DTSTAMP:20260405T134605
CREATED:20220415T170625Z
LAST-MODIFIED:20220420T152935Z
UID:7985-1650960000-1651143600@dev.califesciences.org
SUMMARY:WuXi Healthcare Forum 2022 - Call To Action
DESCRIPTION:We are delighted to share with you the full agenda below for the WuXi Healthcare Forum 2022\, taking place virtually on April 26-28. More than 50 distinguished global leaders will be speaking at this year’s forum\, where thousands of colleagues from around the world will unite once again under this year’s theme\, “Call To Action\,” to support the World Health Organization’s key initiatives in tackling global health challenges head-on\, and to collaboratively advance better healthcare solutions. \n  \n \n  \nComplimentary and open to the global healthcare innovation ecosystem\, this 3-day program will premiere via Zoom from 8am-11am PDT (11am-2pm EDT) daily from April 26-28. To accommodate our global audience\, all registrants will be provided with a link to the on-demand recording of this event. Please log on https://bit.ly/3ucMOgt to register this event and log on https://bit.ly/3jL4Oc5 for speaker bios and program updates. \n  \nAGENDA (The times below are AM\, Pacific Daylight Time | Virtual via Zoom) \n  \nDay 1\, April 26 \n8:00 Welcome & Opening Remarks \nHui Cai\, Program Chair\, VP & Head of Content\, WuXi AppTec Steve Yang\, Co-CEO\, WuXi AppTec \n8:10 Chronic Diseases: Rising to the Challenge A conversation between Sir Menelas Pangalos\, EVP & President\, BioPharmaceuticals R&D\, AstraZeneca\, and Steve Yang\, Co-CEO\, WuXi AppTec \n8:30 Global Health: From Partnership to Worldwide Access A conversation between Emilio Emini\, CEO\, Bill & Melinda Gates Medical Research Institute\, and Zina Affas Besse\, Deputy Head\, Healthcare Private Equity\, AXA Investment Managers Group \n8:50 Call to Action: The Neuro Challenge Walter Koroshetz\, Director\, National Institute of Neurological Disorders & Stroke\, National Institutes of Health \n9:10 Call to Action: The Cardiovascular Challenge A conversation between Mariell Jessup\, Chief Science & Medical Officer\, American Heart Association\, and Faiez Zannad\, Emeritus Professor of Therapeutics & Cardiology\, Université de Lorraine\, Inserm; Chairman\, CVCT\, Paris\, France \n9:35 Call to Action: The Cancer Challenge A conversation between Harold Burstein\, Institute Physician\, Dana-Farber Cancer Institute; Professor of Medicine\, Harvard Medical School\, Arif Kamal\, Chief Patient Officer\, American Cancer Society; Physician Quality & Outcomes Officer\, Duke Cancer Institute\, and Tony Mok\, Li Shu Fan Professor of Clinical Oncology\, The Chinese University of Hong Kong \n10:10 Spotlight on Antimicrobial Resistance Erin Duffy\, Chief of Research & Development\, CARB-X Valeria Gigante\, Team Lead\, AMR Division\, World Health Organization\, Geneva\, Switzerland Timothy Jinks\, Head of Infectious Diseases Interventions\, The Wellcome Trust Henry Skinner\, CEO\, AMR Action Fund Session Leader: Jenny Yip\, Managing Partner\, Adjuvant Capital \n11:00 Day 1 Adjourn \nDay 2\, April 27 \n8:00 Welcome & Opening Remarks \nRichard Soll\, Head of Boston Office & Senior Advisor of Strategic Projects\, WuXi AppTec Minzhang Chen\, Co-CEO\, WuXi AppTec \n8:10 Better. Faster. Smarter. \nStephen Hahn\, CEO-Partner\, Flagship Pioneering; CEO\, Harbinger Health \n8:30 Moving the Needle on Neurological Disorders Laurence Barker\, Partner\, The Dementia Discovery Fund Christina Isacson\, Partner\, Lightstone Ventures Philip Scheltens\, Head\, Dementia Fund\, EQT Life Sciences Session Leader: Rana Al-Hallaq\, Partner\, Pfizer Ventures \n9:05 Spotlight on Parkinson’s Disease \nA conversation between Todd Sherer\, EVP\, Research Strategy\, The Michael J. Fox Foundation for Parkinson’s Research\, and Andrew Siderowf\, Hurtig-Stern Professor in Neurology\, University of Pennsylvania Perelman School of Medicine \n9:30 Revitalizing Cardiovascular R&D \nSekar Kathiresan\, CEO\, Verve Therapeutics Michael Mendelsohn\, Founder & Chairman\, Cardurion Pharmaceuticals Christopher de Souza\, Director\, Broadview Ventures Claudia Ulbrich\, CEO & Co-Founder\, Cardior Pharmaceuticals Session Leader: Simone Fishburn\, VP & Editor in Chief\, BioCentury Inc. \n10:15 Reaching the Next Frontiers in Cancer Therapies Rajesh Chopra\, Venture Partner\, Head of Oncology\, Apple Tree Partners Adam Friedman\, President\, Corporate Strategy & Business Development\, Scorpion Therapeutics Luba Greenwood\, CEO\, Kojin Therapeutics KT Moortgat\, Healthcare Venture Investor\, Investment Partner\, Droia Ventures Lewis Williams\, Co-founder\, Chairman & CEO\, Walking Fish Therapeutics\, Inc. \nSession Leader: Dave Madge\, VP of Discovery Services\, WuXi AppTec \n11:00 Day 2 Adjourn \nDay 3\, April 28 \n8:00 Welcome & Opening Remarks \nJocelyne Bath\, Managing Director\, OXGENE Richard Connell\, SVP & US / EU COO\, WuXi AppTec \n8:10 Healthcare 2030: Current and Future Drivers of Success A conversation between William Hait\, EVP\, Chief External Innovation\, Medical Safety & Global Public Health Officer\, Johnson & Johnson\, and Julie Grant\, General Partner\, Canaan \n8:30 Spotlight on Singapore: The Asia-Pacific Translation Hub for Cell and Gene Therapy in Oncology Andrew Bruce\, CEO\, MediSix Therapeutics Wee Joo Chng\, Executive Director\, Singapore Translational Cancer Consortium; Director & Senior Consultant\, National University Cancer Institute\, Singapore\, NUHS Boon Tong Koh\, Executive Director\, Bioprocessing Technology Institute\, A*STAR\, Singapore Francesca Lim\, Assistant Medical Director\, Cell Therapy Facility\, Health Science Authority (HSA); Senior Consultant Hematologist\, Singapore General Hospital Yann Chong Tan\, Managing Director\, EVX Ventures; CEO\, Nuevocor; CSO\, Cargene Therapeutics Session Leader: Danny Soon\, CEO\, Consortium for Clinical Research & Innovation\, Singapore; Executive Director\, Singapore Clinical Research Institute \n9:30 Spotlight on UK: The Life Science Cluster Standing on the Shoulders of Giants Opening Remarks by Steve Bates\, CEO\, UK BioIndustry Association Billy Boyle\, Co-Founder & CEO\, Owlstone Medical Ryan Cawood\, CSO\, WuXi Advanced Therapies & OXGENE Kathryn Corzo\, COO\, bit.bio Jack O’Meara\, CEO\, Ochre Bio Session Leader: Michael Ward\, Global Head of Life Sciences & Healthcare Thought Leadership\, Clarivate \n10:30 When Technology Meets Healthcare \nVineeta Agarwala\, General Partner\, Andreessen Horowitz Rohit Chandra\, Chief Digital Officer\, Cleveland Clinic Daphne Koller\, CEO & Founder\, insitro Session Leader: Ben Robbins\, Venture Partner\, GV \n11:20 Forum Adjourn
URL:https://dev.califesciences.org/event/wuxi-healthcare-forum-2022/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220412
DTEND;VALUE=DATE:20220415
DTSTAMP:20260405T134605
CREATED:20220225T013713Z
LAST-MODIFIED:20220331T204806Z
UID:6665-1649721600-1649980799@dev.califesciences.org
SUMMARY:Informa: MD&M West
DESCRIPTION:Location: Anaheim Convention Center \n  \nMD&M West is the leading medical device technology and innovation event in the US\, attracting thousands of engineers\, founders and buyers each year in Anaheim\, California. MD&M West is part of IME West\, representing all facets of advanced manufacturing including medical plastics\, packaging\, automation\, prototyping and much more. The three-day expo features more than 1\,500 exhibiting companies plus many conference and networking opportunities. \n  \nRegister»
URL:https://dev.califesciences.org/event/mdm-west/
LOCATION:Anaheim Convention Center\, Anaheim\, CA\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220329T113000
DTEND;TZID=America/Los_Angeles:20220329T121500
DTSTAMP:20260405T134605
CREATED:20220301T004358Z
LAST-MODIFIED:20220301T212752Z
UID:6736-1648553400-1648556100@dev.califesciences.org
SUMMARY:National Life Science Startup Symposium - "FDA For Life Science Companies: The Insiders Guide to FDA Approval"
DESCRIPTION:Kwame Ulmer is a 12 year veteran of the FDA and currently works as a regulatory strategist and investor. You will learn how to develop a regulatory strategy\, maximize your interactions with the FDA and efficiently get your product approved. The presentation is geared towards helping C-Suite executives understand the key levers to drive premarket approval and compliance attractive to investors. The presentation will also discuss overcoming the regulatory challenges during COVID.
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium-fda-for-life-science-companies-the-insiders-guide-to-fda-approval/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220401
DTSTAMP:20260405T134605
CREATED:20220219T000027Z
LAST-MODIFIED:20220331T204215Z
UID:6514-1648512000-1648771199@dev.califesciences.org
SUMMARY:Pismo Ventures: National Life Science Startup Symposium
DESCRIPTION:Location: Virtual \nWe are excited to announce the upcoming National Life Science Startup Symposium on March 29th and 31st. This is a Pismo Ventures Event\, sponsored and presented by The George Washington University and The Society of Physician Entrepreneurs. \nThe website event is: https://lifescience.startupsymposium.com and the Registration Deadline is March 13\, 2022. \nAs members of the organizing committee\, we would like to invite startups to participate in the Symposium. Startup participants have a tremendous opportunity to be seen by hundreds of investors across the country\, and have a chance of being funded by the participating investors.\nThis is our third Symposium. At the last two Symposiums\, we had over 200 startups participating. We also had (and will have for this Symposium) about 150+ Angel investors and 50+ VCs who judge the startup pitches. This dynamic provides tremendous value to both the startups and the investors. The startups get exposures to numerous potential investors\, and the investors get an excellent deal flow to evaluate. A few startups from our previous Symposiums got the attention of the judges/investors and received significant investments subsequently\, e.g. via SPV’s and/or direct angel/VC investments. \nIn addition to providing this opportunity to be seen by a large number of investors\, the Symposium includes the following valuable panels and webinars. \nPanels:\n“Working with University Tech Transfer for Startups”\n“Partnering with Big Pharma\, Diagnostic\, and MedTech Companies for Startups” \nWebinars:\n“Structuring your Startup and Negotiating Financing”\n“FDA For Life Science Companies: The Insiders Guide to FDA Approval” \nWe have already confirmed participation from the following organizations\, and are expecting many more: \n\nGeorge Washington University\nGeorgetown University\nArizona State University\nUniversity of Arizona\nUniversity of California Irvine\nUniversity of California Berkeley\n\nNote: FREE registration for all applicants. \nWe are sure that it will be a great event to increase visibility for startups and also provide them with valuable information and contacts. \nRegister»
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220319T100000
DTEND;TZID=America/Los_Angeles:20220319T170000
DTSTAMP:20260405T134605
CREATED:20220218T233230Z
LAST-MODIFIED:20220225T173409Z
UID:6508-1647684000-1647709200@dev.califesciences.org
SUMMARY:Quest Science Center: Tri-Valley Innovation Fair 2022
DESCRIPTION:Quest Science Center is excited to present an opportunity to connect everyone to the value of science at the 4th Annual Tri-Valley Innovation Fair 2022\, taking place from 10am-5pm on Saturday\, March 19\, 2022 at the Alameda County Fairgrounds. \nTri-Valley Innovation Fair 2022 will take science and learning to a new level\, transforming the Alameda County Fairgrounds into the venue that will showcase the best of Tri-Valley innovation in the fields of Science\, Technology\, Engineering and Math. \nDesigned to bring science and technology to life through fun and interactive activities\, exhibits and program sessions\, the fair will appeal to a diverse audience including families\, educators\, students and curious minds alike. The event will be open to the general public\, showcasing the Tri-Valley to the greater Bay Area – connecting the region’s innovation & education. \nExhibitor Registration is Now Open!\nHow is your business using science and technology to make our lives better? Are you an incubator for new ideas? Can you demonstrate how you’re using data analysis in innovation? Do your scientists or engineers enjoy inspiring students and families? How are you making technology accessible and safe for all? Are you on the brink of discovering the next software or hardware wave of the future? Are you an educator with an amazing class project? \nRegister»
URL:https://dev.califesciences.org/event/quest-science-center-tri-valley-innovation-fair-2022/
LOCATION:Alameda County Fairgrounds\, 4501 Pleasanton Avenue\, Pleasanton\, CA\, 94566\, United States
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220316T110000
DTEND;TZID=America/Los_Angeles:20220316T113000
DTSTAMP:20260405T134605
CREATED:20220302T234427Z
LAST-MODIFIED:20220304T001319Z
UID:6766-1647428400-1647430200@dev.califesciences.org
SUMMARY:Using STEP and SciLeads To Grow Your California Biotech Business
DESCRIPTION:Join the live webinar with Laura Haldane as she introduces SciLeads\, an innovative life science and applied research lead generation platform. SciLeads works with bioscience companies in California and around the world to accelerate their sales by enabling them to quickly find and engage with targeted and funded leads\, and develop outreach strategies. \nAlso joining Laura is Mariana Guevara from the California Governor’s Office of Business and Economic Development who will speak about how the STEP grant program can contribute toward the cost of the SciLeads database subscription. \nRegister»
URL:https://dev.califesciences.org/event/using-step-and-scileads-to-grow-your-california-biotech-business/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220315T073000
DTEND;TZID=America/Los_Angeles:20220315T170000
DTSTAMP:20260405T134605
CREATED:20220218T232315Z
LAST-MODIFIED:20220225T000143Z
UID:6502-1647329400-1647363600@dev.califesciences.org
SUMMARY:Fierce Pharma: BD&L Summit - Deal-Making Insights for the Life Sciences Industry
DESCRIPTION:Successfully identify and execute strategic partnerships\, licensing\, and M&A Deals \nThe Fierce Business Development and Licensing (BD&L) Summit for Life Sciences returns LIVE in 2022 bringing together key deal-makers and serving as an open forum for cross-functional business development\, due diligence\, finance\, and legal teams to share valuable insights and actionable strategies on successfully sourcing and evaluating new opportunities\, conducting due diligence\, and structuring licensing agreements and M&A deals. \nCLS Members receive 25% off your registration using code CALS at checkout!  \nRegister»
URL:https://dev.califesciences.org/event/bdl-summit-deal-making-insights-for-the-life-sciences-industry/
LOCATION:Hyatt Centric Fisherman’s Wharf San Francisco\, 555 North Point Street\, San Francisco\, 94133\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220309
DTEND;VALUE=DATE:20220311
DTSTAMP:20260405T134605
CREATED:20220224T234342Z
LAST-MODIFIED:20220225T163553Z
UID:6644-1646784000-1646956799@dev.califesciences.org
SUMMARY:MDMA: 2022 FDA Forum
DESCRIPTION:MDMA’s 2022 FDA Forum will feature senior officials from FDA and industry and focus on the\nkey regulatory issues impacting the medical device industry. \nDesigned specifically for medical device regulatory professionals and executive decision makers\,\nMDMA’s FDA Forum promises to deliver key regulatory insights and preview trends\nthat will impact your regulatory and business strategies. \nTopics will include: \nFDA’s Continued COVID-19 Response\nNavigating 510(k)\, De Novo\, PMA Programs\nDigital Health\nCDRH Update\nBest Practices for Pre-Submission meetings\nEmerging Issues (Biocompatibility\, Supply Chain & More)\nMDUFA Update \nThis conference is pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion \nCLS Members receive $100 off registration using code STATE at checkout.  \n  \nRegister»
URL:https://dev.califesciences.org/event/mdma-2022-fda-forum/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220303T073000
DTEND;TZID=America/Los_Angeles:20220303T100000
DTSTAMP:20260405T134605
CREATED:20220224T232202Z
LAST-MODIFIED:20220224T235758Z
UID:6636-1646292600-1646301600@dev.califesciences.org
SUMMARY:SF Business Times: Women Who Lead in Life Sciences
DESCRIPTION:Join us for a timely discussion about the state of diversity in this regions booming life sciences industry. How many women have made it into the C-Suite\, the boardroom\, the labs\, and what does the leadership pipeline look like? We’ll talk with women in top roles about their personal stories and hear their views on how life sciences companies are transforming culture\, policies and programs that will result in more equity and opportunity for women. \nThis will be a lively Q&A format\, moderated by San Francisco Business Times biotech reporter\, Ron Leuty. \n \nFor more information\, please contact Felicia Brown at fbrown@bizjournals.com
URL:https://dev.califesciences.org/event/women-who-lead-in-life-sciences/
LOCATION:Hyatt Regency San Francisco\, 5 Embarcadero\, CA\, United States
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220222T160000
DTEND;TZID=America/Los_Angeles:20220222T180000
DTSTAMP:20260405T134605
CREATED:20220218T174339Z
LAST-MODIFIED:20220225T170324Z
UID:6479-1645545600-1645552800@dev.califesciences.org
SUMMARY:Women in Bio - SoCal Chapter Presents "Rare Disease 8: Intersecting Access & Diversity for Underserved Communities"
DESCRIPTION:Join us for a discussion on improving patient access to healthcare in under-represented communities\, the importance of diversifying clinical trials\, and exploring rare diseases that affect Black\, Indigenous\, and People of Color (BIPOC) women. \nRegister»
URL:https://dev.califesciences.org/event/women-in-bio-socal-chapter-presents-rare-disease-8-intersecting-access-diversity-for-underserved-communities/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
END:VCALENDAR